Priority Signals
Signal Sources
this weekYour Programs
Signal Feed
Pipeline Landscape
USPTO + EPO Filing VelocityCPC A61K31/519 · A61P35/00 · 2022–2026 YTD
Source: USPTO PatentsView API + EPO OPS · Updated May 17, 2026
12-month activityby assignee
CPC subcode split2025–2026 filings
Roche CDK4/6 Continuation Chain11 continuations · 2016–2026
Red = active FTO risk (XYZ-002). Roche files continuations every 18–24 months, systematically broadening Markush scope as competitors advance to Phase 2.
Claim scope analysis — US11,842,190 B2Roche · Filed May 9, 2026 · CDK4/6
Assessment against XYZ-001 and XYZ-002. IP counsel review recommended before next IND meeting.